So far, it has been demonstrated that expression of serine/arginine-rich splicing factor 2 (SRSF2) in renal cell carcinoma patients (RCC) is involved in the regulation of IC expression (inter alia BTLA), which in turn modulates TILs’ exhaustion. The gene discussed is SRSF2; the disease is hereditary clear cell renal cell carcinoma.